These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study. Chia PY; Ong SWX; Chiew CJ; Ang LW; Chavatte JM; Mak TM; Cui L; Kalimuddin S; Chia WN; Tan CW; Chai LYA; Tan SY; Zheng S; Lin RTP; Wang L; Leo YS; Lee VJ; Lye DC; Young BE Clin Microbiol Infect; 2022 Apr; 28(4):612.e1-612.e7. PubMed ID: 34826623 [TBL] [Abstract][Full Text] [Related]
6. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Singanayagam A; Hakki S; Dunning J; Madon KJ; Crone MA; Koycheva A; Derqui-Fernandez N; Barnett JL; Whitfield MG; Varro R; Charlett A; Kundu R; Fenn J; Cutajar J; Quinn V; Conibear E; Barclay W; Freemont PS; Taylor GP; Ahmad S; Zambon M; Ferguson NM; Lalvani A; Lancet Infect Dis; 2022 Feb; 22(2):183-195. PubMed ID: 34756186 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of Vaccine Breakthrough Infections by SARS-CoV-2 Delta Variant. Zhang M; Liang Y; Yu D; Du B; Cheng W; Li L; Yu Z; Luo S; Zhang Y; Wang H; Zhang X; Zhang W Int J Biol Sci; 2022; 18(2):889-900. PubMed ID: 35002532 [TBL] [Abstract][Full Text] [Related]
8. Infection With the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Delta Variant Is Associated With Higher Recovery of Infectious Virus Compared to the Alpha Variant in Both Unvaccinated and Vaccinated Individuals. Huai Luo C; Paul Morris C; Sachithanandham J; Amadi A; Gaston DC; Li M; Swanson NJ; Schwartz M; Klein EY; Pekosz A; Mostafa HH Clin Infect Dis; 2022 Aug; 75(1):e715-e725. PubMed ID: 34922338 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of SARS-CoV-2 Variants of Concern and Variants of Interest in COVID-19 Breakthrough Infections in a Hospital in Monterrey, Mexico. Galán-Huerta KA; Flores-Treviño S; Salas-Treviño D; Bocanegra-Ibarias P; Rivas-Estilla AM; Pérez-Alba E; Lozano-Sepúlveda SA; Arellanos-Soto D; Camacho-Ortiz A Viruses; 2022 Jan; 14(1):. PubMed ID: 35062359 [TBL] [Abstract][Full Text] [Related]
10. Distribution of SARS-CoV-2 Variants in a Large Integrated Health Care System - California, March-July 2021. Malden DE; Bruxvoort KJ; Tseng HF; Ackerson B; Choi SK; Florea A; Tubert J; Takhar H; Aragones M; Hong V; Talarico CA; McLaughlin JM; Qian L; Tartof SY MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(40):1415-1419. PubMed ID: 34618801 [TBL] [Abstract][Full Text] [Related]
11. Trends and Correlates of Breakthrough Infections With SARS-CoV-2. Yamal JM; Appana S; Wang M; Leon-Novelo L; Bakota E; Ye Y; Sharma S; Morrison AC; Marko D; Linder SH; Rector A; Jetelina KK; Boerwinkle E; de Oliveira Otto M Front Public Health; 2022; 10():856532. PubMed ID: 35619825 [TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants. Kislaya I; Rodrigues EF; Borges V; Gomes JP; Sousa C; Almeida JP; Peralta-Santos A; Nunes B; Emerg Infect Dis; 2022 Feb; 28(2):331-337. PubMed ID: 34876242 [TBL] [Abstract][Full Text] [Related]
13. Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers. Ali AM; Tofiq AM; Rostam HM; Ali KM; Tawfeeq HM J Med Virol; 2022 Dec; 94(12):5867-5876. PubMed ID: 36029103 [TBL] [Abstract][Full Text] [Related]
14. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999 [TBL] [Abstract][Full Text] [Related]
15. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359 [TBL] [Abstract][Full Text] [Related]
16. Absence of antibody responses to SARS-CoV-2 N protein in COVID-19 vaccine breakthrough cases. Vu LD; Wallace S; Phan AT; Christofferson RC; Turner E; Parker S; Elkind-Hirsch K; Landry D; Stansbury A; Rose R; Nolan DJ; Lamers SL; Hirezi M; Ogden B; Cormier SA Exp Biol Med (Maywood); 2022 Nov; 247(21):1923-1936. PubMed ID: 36408542 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 Vaccine Effectiveness and Breakthrough Infections Among Patients Receiving Maintenance Dialysis. Manley HJ; Li NC; Aweh GN; Hsu CM; Weiner DE; Miskulin D; Harford AM; Johnson D; Lacson E Am J Kidney Dis; 2023 Apr; 81(4):406-415. PubMed ID: 36462570 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Infections and Hospitalizations Among Persons Aged ≥16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021. Griffin JB; Haddix M; Danza P; Fisher R; Koo TH; Traub E; Gounder P; Jarashow C; Balter S MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1170-1176. PubMed ID: 34437525 [TBL] [Abstract][Full Text] [Related]
19. Transmission and Infectious SARS-CoV-2 Shedding Kinetics in Vaccinated and Unvaccinated Individuals. Jung J; Kim JY; Park H; Park S; Lim JS; Lim SY; Bae S; Lim YJ; Kim EO; Kim J; Park MS; Kim SH JAMA Netw Open; 2022 May; 5(5):e2213606. PubMed ID: 35608859 [TBL] [Abstract][Full Text] [Related]
20. Postvaccination SARS-COV-2 among Health Care Workers in New Jersey: A Genomic Epidemiological Study. Mathema B; Chen L; Chow KF; Zhao Y; Zody MC; Mediavilla JR; Cunningham MH; Composto K; Lee A; Oschwald DM; Germer S; Fennessey S; Patel K; Wilson D; Cassell A; Pascual L; Ip A; Corvelo A; Dar S; Kramer Y; Maniatis T; Perlin DS; Kreiswirth BN Microbiol Spectr; 2021 Dec; 9(3):e0188221. PubMed ID: 34787439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]